Experience with totally implantable venous access devices in cystic fibrosis patients Source: Eur Respir J 2003; 22: Suppl. 45, 502s Year: 2003
Totally implantable venous access devices in patients with cystic fibrosis Source: Annual Congress 2008 - Cystic fibrosis: a disease with many aspects Year: 2008
Candidaemia in cystic fibrosis patients with totally implantable venous access devices is associated with invasive procedures and exacerbation frequency Source: International Congress 2015 – Cystic fibrosis: microbiology, immunology and assessment Year: 2015
Imaging for insertion of indwelling venous access devices in patients with cystic fibrosis Source: Annual Congress 2010 - New aspects of cystic fibrosis Year: 2010
Does I.V. continuous antibiotic treatment increase the risk of totally implantable vascular devices complications in CF? Source: Eur Respir J 2005; 26: Suppl. 49, 620s Year: 2005
Complications of a permanently implanted port system for continuous epoprostenol treatment in pulmonary hypertension Source: Eur Respir J 2002; 20: Suppl. 38, 597s Year: 2002
Totally implantable central venous access ports for M/XDR-TB treatment Source: International Congress 2017 – MDRTB: detection and management Year: 2017
Evaluation of three devices and one technique for pulmonary drainage in a CF patient Source: Eur Respir J 2006; 28: Suppl. 50, 435s Year: 2006
The use of Pezzer catheter in cases of persistent airleak in advanced cystic fibrosis Source: Annual Congress 2012 - Cystic fibrosis (adults and children): risk factors and clinical problems Year: 2012
Effectiveness of mechanical insufflation-exsufflation device in pediatric patients with cystic fibrosis Source: International Congress 2018 – Cystic fibrosis in paediatric patients: current research Year: 2018
Endovascular stripping as a valuable tool to treat distal occlusions of totally implantable vascular devices in CF Source: Eur Respir J 2005; 26: Suppl. 49, 621s Year: 2005
Broviac catheter complications of intravenous epoprostenol therapy in patients with pulmonary arterial hypertension Source: Eur Respir J 2004; 24: Suppl. 48, 636s Year: 2004
Procedural safety of a fully implantable pump for delivery of intravenous prostanoids in severe pulmonary hypertension: A two-center observational study Source: International Congress 2016 – Pulmonary hypertension: the clinic I Year: 2016
Home intravenous antibiotic treatments in cystic fibrosis adult patients Source: Eur Respir J 2002; 20: Suppl. 38, 158s Year: 2002
Use of noninvasive mechanical ventilation in patients with cystic fibrosis Source: Annual Congress 2010 - New aspects of cystic fibrosis Year: 2010
Spontaneous flow increase from implantable pump for intravenous treprostinil delivery Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside Year: 2016
The epidemiology and invasive therapy of portal hypertension in cystic fibrosis Source: Eur Respir J 2001; 18: Suppl. 33, 127s Year: 2001
Impact of a wireless implanted pulmonary artery pressure monitoring system in heart failure patients with comorbid chronic obstructive pulmonary disease Source: Annual Congress 2012 - Pulmonary circulation: clinical diagnosis, treatment, end-points and animal models Year: 2012
Benefits of a reservoir nasal cannula (Oxymizer®) vs. a conventional nasal cannula during exercise in hypoxemic patients with pulmonary fibrosis Source: International Congress 2015 – Latest insights into chronic care Year: 2015
Usefulness of open lung biopsy in patients undergoing mechanical ventilation for undiagnosed pulmonary infiltrate: importance of comorbidity and organ failure Source: Eur Respir J 2006; 28: Suppl. 50, 346s Year: 2006